Examining the stability of a new aspheric IOL in cataract patients

Ophthalmology Times EuropeOphthalmology Times Europe March 2021
Volume 17
Issue 2

A new monofocal IOL was found to provide stability in the capsular bag 1 week and 1 month after implantation, with good refractive outcomes.

Evaluation during cataract surgery

Patients who wish to reduce their reliance on glasses have high expectations of their visual outcomes after cataract surgery. To meet their demands, lens technology has advanced significantly, particularly with the introduction of aspheric IOLs, which are designed to reproduce the natural shape of the crystalline lens to improve visual quality and contrast sensitivity.1

To achieve the best visual outcomes from advanced lens technology, lens stability in the capsular bag is essential. I recently studied the anterior chamber stability of the newly introduced CT Lucia 621 P (Carl Zeiss Meditec), a monofocal aspheric hydrophobic acrylic IOL with a heparin-coated surface (Figure 1).

It is important to know the patient’s anterior chamber depth before surgery, which allows us to calculate the IOL power accurately. After surgery, it helps us determine the stability of the IOL in the capsular bag and assess the patient’s refractive outcome.

Lens design

The bi-sign design of CT Lucia IOLs compensates for a number of aberrations resulting from IOL misalignment or the corneal contour, providing the benefits of neutral and correcting aspheric IOLs and improving retinal image quality.2 The single-pieceC-loop CT Lucia 621P follows the previously introduced monofocal spherical CT Lucia 211P and aspheric 611P(Y), in addition to other Zeiss monofocal IOLs.

It has a 6-mm-diameter optic and 13-mm total diameter and is available from +0.0 to +34.0 D in 0.5-D increments. The lens has step-vaulted haptics and a reinforced optic-haptic junction to promote stability in the capsular bag, for improved lens centration, refractive predictability and long-term visual outcomes.

Ease of use of the injector is an important consideration for surgeons and surgical staff. This lens comes fully preloaded in a redesigned injection system that makes injection easier, faster and safer than before.

As the injector is advanced to the intermediate position, there is an audible click. The ramp stop helps the surgeon apply the correct pressure to the thumb flange to release the IOL.

Assessing lens stability

Within a 1-month period, I implanted this monofocal lens in 60 eyes of 60 patients who ranged in age from 51 to 91 years. It was used in every patient having cataract surgery; there were no specific inclusion or exclusion criteria. Therefore, this protocol reflected our daily experience as cataract surgeons in performing routine cataract surgery with monofocal IOLs and demonstrated the typical clinical behaviour of the IOL in this setting.

I examined the stability of the IOL by measuring anterior chamber depth with biometry (IOLMaster 700, Carl Zeiss Meditec). Preoperatively, the mean anterior chamber depth was 3.13 mm.

After surgery, the anterior chamber depth was measured twice: after 1 week and then 1 month later. Anterior chamber depth measurements indicated good stability within the capsular bag, without the IOL position changing significantly, whether patients were hyperopic or myopic. At 1 week, the mean anterior chamber depth was 5.36 mm and at 1 month it was 5.34 mm.

No patients had complications, nor did they report glare or other light-related disturbances. They had very good refractive outcomes that were consistent with the expected calculations of the biometer, indicating that the lens was very stable in the bag from the first week after surgery. The mean corrected visual acuity was 10/10.

The injector system was very easy to use and performed well with the 60 lenses we implanted. One lens got stuck in the injector, but this was remedied and otherwise we had no issues. The learning curve was very easy; our experience was reproducible and we had good reliability.

The IOL opens very quickly when injected and there were no problems with the optics. When the manufacturer questioned surgeons and nurses about the system, most reported that they preferred it over their reusable injector of choice.3

CT Lucia 621 P

Surgical pearls

Based on my experience with the CT Lucia 621P, I would like to offer some advice for implanting it. It is very important to use the correct amount of viscoelastic during the procedure to help the IOL slide across the injector and unfold correctly in the capsular bag.

If too much viscoelastic is used, the lens will slide across the injector but open slowly in the capsular bag because the haptic will stick to the plate of the lens. In contrast, if there is not enough viscoelastic, the lens will not slide across the injector properly and a haptic may break.

It is also necessary in general to be especially careful with higher-power lenses because they are thicker and a bit more rigid. However, we did not have problems with higher-power versions of this lens.


In my experience, the CT Lucia 621P maintained stability in the capsular bag 1 week and 1 month after implantation and provided good refractive outcomes. The redesigned injector system was easy to use and provided smooth delivery of the IOL into the capsular bag.


Antonino Cuttitta, MD
E: studiooculisticocuttitta@gmail.com
Dr Cuttitta is head of ophthalmology at Clinica Andros, Palermo, Italy. He has no financial disclosures related to this article.


  1. Schuster AK, Tesarz J, Vossmerbaeumer U. The impact on vision of aspheric to spherical monofocal intraocular lenses in cataract surgery: a systematic review with meta-analysis. Ophthalmology. 2013;120:2166–2175.
  2. Portney V. New bi-sign aspheric IOL and its application. Optom Vis Sci. 2012;89:80–89.
  3. Carl Zeiss Meditec. CT LUCIA 621P. Surgeon evaluation report (April to September 2019). Report on surgery performance of CT LUCIA 621P injector.
Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.